Phase 2 study of Remura for the treatment of dry eye disease - ONA
Links shared publicly online about this topic.
- 840total visits
Phase 2 study of Remura for the treatment of dry eye disease - ONA
View full resource at oncologynurseadvisor.com
Tags: Eye, Disease and Condition, Pharma, Phase 2 Clinical Trial, disease
Most Recently Shared on September 28, 2010 at 7:37 pm By:
Phase 2 study of Remura for the treatment of dry eye disease http://goo.gl/fb/XzoD7
Phase 2 study of RGN-259 for the treatment of dry eye - MPR
empr.com — “RegeneRx Biopharmaceuticals announced that the first patient has been screened and is being enrolled in a Phase 2 clinical trial testing the Company's drug candidate RGN-259 in patients with dry eye associated with graft vs. host disease.” View full resource at empr.com
Most Recently Shared on December 23, 2010 at 6:23 pm By:
MPR News: Phase 2 study of RGN-259 for the treatment of dry eye: RegeneRx Biopharmaceuticals announced that the ... http://bit.ly/igw6rT
Phase 2 study of Remura for the treatment of dry eye disease - MPR
empr.com — “ISTA Pharmaceuticals announced the results from its Phase 2 trial of Remura (bromfenac ophthalmic solution) for the treatment of dry eye disease.” View full resource at empr.com
Most Recently Shared on September 28, 2010 at 8:14 pm By:
MPR News: Phase 2 study of Remura for the treatment of dry eye disease: ISTA Pharmaceuticals announced the results... http://bit.ly/cdMte8
Resolvyx Announces Positive Data from Phase 2 Clinical Trial of the Resolvin RX-10045 in Patients with Dry Eye Syndrome
businesswire.com — “Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced positive data from a Phase 2 clinical study evaluating RX-1” View full resource at businesswire.com
Most Recently Shared on August 24, 2009 at 11:40 am By:
New drug in clinical trials for the treatment of dry eye disease... http://tiny.cc/lM8UU
Advertisement

